CRVSNasdaq

Corvus Pharmaceuticals, Inc.

Pharmaceutical Preparations · DE · CIK 1626971

Developing drug candidates that precisely target proteins critical to immune cell function for immune-mediated diseases and cancers

red 8-K · 90d

$1.00B

Market cap

$14.48

Last close

+7.3%

+15.3%

1.5M

Volume

Price · last 39 sessions-9.6%

May 4L $11.12 · H $16.02Jun 29

218

Total filings

Jun 12, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance